A serum three-microRNA panel: promising biomarkers for renal cell carcinoma screening

Journal of Cancer Metastasis and Treatment · Published 2025-04-27 · DOI 10.20517/2394-4722.2024.122

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.20517/2394-4722.2024.122

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Optimal approach to stem cell mobilization in transplant-eligible multiple myeloma patients · Journal of Cancer Metastasis and Treatment · 2024 · Same journal
• Renin-angiotensin-system and clear cell renal carcinoma: research advances and future perspectives · Journal of Cancer Metastasis and Treatment · 2024 · Same journal
• Knockdown of the EEF1A2 gene reduces lung cancer brain metastasis by downregulating the BCL10/NFκB pathway · Journal of Cancer Metastasis and Treatment · 2025 · Same journal
• Emerging surgical optimization strategies for early-stage cervical cancer: insights from global evidence and Chinese research contributions · Journal of Cancer Metastasis and Treatment · 2026 · Same journal
• Expert consensus on administering oncolytic viruses for gynecological cancers in China · Journal of Cancer Metastasis and Treatment · 2026 · Same journal
• Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma · Journal of Cancer Metastasis and Treatment · 2024 · Same journal
• Lung metastasis in soft tissue sarcomas: survival and risk factors using the SEER database · Journal of Cancer Metastasis and Treatment · 2025 · Same journal
• Censor-aware semi-supervised survival time prediction in lung cancer using clinical and radiomics features · Journal of Cancer Metastasis and Treatment · 2025 · Same journal
• Perioperative therapies for metastatic renal cell carcinoma · Journal of Cancer Metastasis and Treatment · 2025 · Same journal
• The lnc-MAPKAPK5-AS1 promotes colon cancer-derived liver metastasis via modulating the tumor microenvironment: an in silico study and immunohistochemistry validation · Journal of Cancer Metastasis and Treatment · 2025 · Same journal